Faes Farma S.A [FAE] vs Labiana Health S.A [LAB] Detailed Stock Comparison
Faes Farma S.A
BME
Loading...
Labiana Health S.A
BME
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Faes Farma S.A wins in 11 metrics, Labiana Health S.A wins in 5 metrics, with 0 ties. Faes Farma S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Faes Farma S.A | Labiana Health S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.41 | N/A | N/A |
| Price-to-Book Ratio | 1.80 | 5.80 | Faes Farma S.A |
| Debt-to-Equity Ratio | 11.48 | 1,378.08 | Faes Farma S.A |
| PEG Ratio | 14.55 | N/A | N/A |
| EV/EBITDA | 10.93 | 20.19 | Faes Farma S.A |
| Profit Margin (TTM) | 19.37% | 0.38% | Faes Farma S.A |
| Operating Margin (TTM) | 18.19% | 3.32% | Faes Farma S.A |
| EBITDA Margin (TTM) | 18.19% | 3.32% | Faes Farma S.A |
| Return on Equity | 14.83% | 6.92% | Faes Farma S.A |
| Return on Assets (TTM) | 6.92% | 5.72% | Faes Farma S.A |
| Free Cash Flow (TTM) | $75.95M | $-4.68M | Faes Farma S.A |
| Dividend Yield | 6.64% | N/A | N/A |
| 1-Year Return | 19.89% | 25.81% | Labiana Health S.A |
| Price-to-Sales Ratio (TTM) | 2.42 | 0.41 | Labiana Health S.A |
| Enterprise Value | $1.28B | $66.63M | Faes Farma S.A |
| EV/Revenue Ratio | 2.35 | 1.14 | Labiana Health S.A |
| Gross Profit Margin (TTM) | 69.26% | 147.79% | Labiana Health S.A |
| Revenue per Share (TTM) | $2 | N/A | N/A |
| Earnings per Share (Diluted) | $0.34 | $-0.16 | Faes Farma S.A |
| Beta (Stock Volatility) | 0.33 | -0.44 | Labiana Health S.A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Faes Farma S.A vs Labiana Health S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Faes Farma S.A | 0.00% | -2.09% | -6.43% | -1.17% | 15.30% | 20.23% |
| Labiana Health S.A | 1.04% | 5.41% | 16.77% | 20.37% | 34.48% | 32.65% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Faes Farma S.A | 19.89% | 7.11% | 21.97% | 67.46% | 66.80% | -47.38% |
| Labiana Health S.A | 25.81% | 6,400.00% | 1,081.82% | 387.50% | 387.50% | 387.50% |
Performance & Financial Health Analysis: Faes Farma S.A vs Labiana Health S.A
| Metric | FAE | LAB |
|---|---|---|
| Market Information | ||
| Market Cap | €1.31B | €27.87M |
| Market Cap Category | Large cap | Small cap |
| 10 Day Avg. Volume | 219,874 | 17,783 |
| 90 Day Avg. Volume | 212,247 | 8,556 |
| Last Close | €4.22 | €3.90 |
| 52 Week Range | €3.27 - €4.73 | €1.86 - €4.00 |
| % from 52W High | -10.78% | -2.50% |
| All-Time High | €19.40 (Feb 05, 2007) | €3.96 (Jul 10, 2025) |
| % from All-Time High | -78.25% | -1.52% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.04% |
| Quarterly Earnings Growth | -0.14% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.19% | 0.00% |
| Operating Margin (TTM) | 0.18% | 0.03% |
| Return on Equity (TTM) | 0.15% | 0.07% |
| Debt to Equity (MRQ) | 11.48 | 1,378.08 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €2.34 | €0.67 |
| Cash per Share (MRQ) | €0.36 | €0.01 |
| Operating Cash Flow (TTM) | €101.14M | €7.19M |
| Levered Free Cash Flow (TTM) | €42.79M | €6.02M |
| Dividends | ||
| Last 12-Month Dividend Yield | 6.64% | N/A |
| Last 12-Month Dividend | €0.30 | N/A |
Valuation & Enterprise Metrics Analysis: Faes Farma S.A vs Labiana Health S.A
| Metric | FAE | LAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.41 | N/A |
| Forward P/E | 14.55 | 4.33 |
| PEG Ratio | 14.55 | N/A |
| Price to Sales (TTM) | 2.42 | 0.41 |
| Price to Book (MRQ) | 1.80 | 5.80 |
| Market Capitalization | ||
| Market Capitalization | €1.31B | €27.87M |
| Enterprise Value | €1.28B | €66.63M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.35 | 1.14 |
| Enterprise to EBITDA | 10.93 | 20.19 |
| Risk & Other Metrics | ||
| Beta | 0.33 | -0.44 |
| Book Value per Share (MRQ) | €2.34 | €0.67 |
Financial Statements Comparison: Faes Farma S.A vs Labiana Health S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | FAE | LAB |
|---|---|---|
| Revenue/Sales | €134.64M | €10.58M |
| Cost of Goods Sold | €41.38M | €-5.06M |
| Gross Profit | €93.25M | €15.63M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | €42.59M | €9.07M |
| EBITDA | €42.59M | €11.11M |
| Pre-Tax Income | €32.86M | €7.05M |
| Income Tax | €5.01M | €0 |
| Net Income (Profit) | €27.85M | €7.05M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | FAE | LAB |
|---|---|---|
| Cash & Equivalents | €64.22M | €2.52M |
| Total Current Assets | €333.73M | €28.76M |
| Total Current Liabilities | €103.46M | €35.06M |
| Long-Term Debt | N/A | €18.19M |
| Total Shareholders Equity | €726.62M | €6.91M |
| Retained Earnings | €209.04M | €-8.94M |
| Property, Plant & Equipment | €300.94M | €1.23M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | FAE | LAB |
|---|---|---|
| Operating Cash Flow | N/A | €-7.21M |
| Capital Expenditures | N/A | €-397,000 |
| Free Cash Flow | N/A | €-2.17M |
| Debt Repayment | N/A | €-232,000 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FAE | LAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 219,874 | 17,783 |
| Average Daily Volume (90 Day) | 212,247 | 8,556 |
| Shares Outstanding | 311.25M | 7.22M |
| Float Shares | 256.60M | N/A |
| % Held by Insiders | 0.13% | 0.72% |
| % Held by Institutions | 0.20% | 0.00% |
Dividend Analysis & Yield Comparison: Faes Farma S.A vs Labiana Health S.A
| Metric | FAE | LAB |
|---|---|---|
| Last 12-Month Dividend | €0.30 | N/A |
| Last 12-Month Dividend Yield | 6.64% | N/A |
| 3-Year Avg Annual Dividend | €0.16 | N/A |
| 3-Year Avg Dividend Yield | 2.25% | N/A |
| 3-Year Total Dividends | €0.49 | N/A |
| Ex-Dividend Date | Jul 03, 2025 | N/A |